FOR IMMEDIATE RELEASE

Contact:  Heather M. Tarczan
312-738-5829
htarczan@medicaldistrict.org

Chicago Area Patient Centered Outcomes Research Network (CAPriCORN) to Help Determine Best Aspirin Dose to Protect Patients with Heart Disease


First PCORnet Demonstration Study Could Help Guide Treatment Options for Millions


May 18, 2015  – Chicago Area Patient Centered Outcomes Research Network (CAPriCORN) will play a key role in a new $14 million research study announced today by the Patient-Centered Outcomes Research Institute (PCORI) to determine the best daily dose of aspirin to use in preventing heart attacks and strokes among people living with heart disease.  CAPriCORN is one of six health system-based data networks that will conduct the three-year clinical trial funded by
PCORI

 

Please open attachment below to read more....

 

 

Attachments:
Download this file (AdaptableTrial_May182015.pdf)AdaptableTrial_May182015.pdf[ ]414 kB

News Archive